9th European Multidisciplinary Meeting on Urological Cancers (EMUC17) Multidisciplinary strategies in urogenital cancers

Transcription

1 9th European Multidisciplinary Meeting on Urological Cancers (EMUC17) Multidisciplinary strategies in urogenital cancers Friday, 17 November Welcome and Introduction Medical oncologist Thomas Powles, London (GB) - ESMO Radiation oncologist Peter Hoskin, Northwood (GB) - ESTRO Urologist Hein van Poppel, Leuven (BE) - EAU Detection and treatment of clinically significant prostate cancer Chairs: Radiologist - Raymond Oyen, Leuven (BE) Radiation oncologist - Thomas Wiegel, Ulm (DE) Urologist - Francesco Montorsi, Milan (IT) MRI before biopsy for all men? YES vs NO Urologist - Hashim Ahmed, London (GB) Radiologist - Harriet Thoeny, Berne (CH) Radiologist - Olivier Rouvière, Lyon (FR) Urologist - Jochen Walz, Marseille (FR) Last judgement: Urologist - Nicolas Mottet, Saint-Étienne (FR) Index lesion in prostate cancer: Myth or reality? Pathologist - Mark Rubin, New York (US) Questions and answers Will level 1 evidence influence our practice in focal therapy? YES Urologist - Mark Emberton, London (GB) vs NO Radiation oncologist - Alberto Bossi, Villejuif (FR) Discussion Last judgement: Urologist - Arnauld Villers, Lille (FR) The optimal primary treatment of prostate cancer: A focus on the ProtecT study Chairs: Radiologist - Raymond Oyen, Leuven (BE) Radiation oncologist - Thomas Wiegel, Ulm (DE) Urologist - Francesco Montorsi, Milan (IT) ProtecT: What have we learnt? Radiation oncologist - Malcolm Mason, Cardiff (GB)

2 Would modern staging change the results? Urologist - Silvan Boxler, Berne (CH) The statistician point of view Biostatistician - Mahesh Parmar, London (GB) Discussion Coffee break and poster viewing Immunotherapy in urological cancers Chairs: Medical oncologist - David McDermott, Boston (US) Urologist - Alexander Govorov, Moscow (RU) Pathologist - Rodolfo Montironi, Ancona (IT) Biological basics of immune therapy Medical oncologist - David McDermott, Boston (US) Prostate cancer Medical oncologist - Silke Gillessen, St. Gallen (CH) Bladder cancer Medical oncologist - Andrea Necchi, Milan (IT) Kidney cancer Medical oncologist - Thomas Powles, London (GB) Discussion Summary of EAU Prostate Cancer Centre Consensus Meeting (EPCCCM ) Urologist - Manfred Wirth, Dresden (DE) Lunch break and poster viewing Industry session Educational session on testis cancer Chairs: Clinical oncologist - Jan Oldenburg, Oslo (NO) Radiation oncologist - Peter Hoskin, Northwood (GB) Urologist - Fred Witjes, Nijmegen (NL) Pathologist - Michelangelo Fiorentino, Bologna (IT) Management of stage 1 Urologist - Peter Albers, Düsseldorf (DE) Management of metastatic disease Medical oncologist - Karim Fizazi, Villejuif (FR) Case discussion Stage I seminoma Case presenter : Clinical oncologist - Jan Oldenburg, Oslo (NO)

3 Urologist - Peter Albers, Düsseldorf (DE) Medonc view: Medical oncologist - Karim Fizazi, Villejuif (FR) Radonc view: Radiation oncologist - Gert De Meerleer, Leuven (BE) Case discussion Residual disease Case presenter : Clinical oncologist - Jan Oldenburg, Oslo (NO) Urologist - Peter Albers, Düsseldorf (DE) Medical oncologist - Karim Fizazi, Villejuif (FR) Radiation oncologist - Gert De Meerleer, Leuven (BE) Best of journals session: Radiotherapy Chairs: Radiation oncologist - Bradley Pieters, Amsterdam (NL) Radiation oncologist - Ananya Choudhury, Machester (UK) Coffee break and poster viewing Educational session on bladder cancer Chairs: Radiotherapist - Anne Kiltie, Oxford (GB) Urologist - George Thalmann, Berne (CH) Pathologist - Antonio Lopez-Beltran, Lisbon (PT) Medical oncologist - Maria De Santis, Coventry (GB) Bladder preservation: How and for whom? Radiation oncologist - Nicholas James, Birmingham (GB) Lymph node dissection: How high is enough? Urologist - Stephen Boorjian, Rochester (US) Molecular sub-types and implications for prognosis and therapy Pathologist - Antonio Lopez-Beltran, Lisbon (PT) Case discussion Case presenter: Urologist - George Thalmann, Berne (CH) Radiation oncologist - Nicholas James, Birmingham (GB) Urologist - Stephen Boorjian, Rochester (US) Medical oncologist - Maria De Santis, Coventry (GB) Industry session Saturday, 18 November Announcement 3 best unmoderated posters Chairs: Clinical oncologist - Jan Oldenburg, Oslo (NO) Urologist - Michiel Sedelaar, Nijmegen (NL) Oligometastatic kidney cancer

4 Chairs: Radiation oncologist - Vincent Khoo, London (GB) Urologist - Hein Van Poppel, Leuven (BE) Medical oncologist - Thomas Powles, London (GB) Pathologist - Ferran Algaba, Barcelona (ES) The optimal timing of cytoreductive nephrectomy Urologist - Axel Bex, Amsterdam (NL) Expanding knowledge of adjuvant therapy Urologist - Karim Bensalah, Rennes (FR) Potential biomarkers for decision making Urological researcher - Kerstin Junker, Homburg (DE) Can local ablation delay the use of systemic therapy for oligometastasis - Radiation therapy Radiation oncologist - Piet Ost, Ghent (BE) Case discussion Case presenter: Urologist - Umberto Capitanio, Milan (IT) Urologist - Axel Bex, Amsterdam (NL) Urologist - Karim Bensalah, Rennes (FR) Urological researcher - Kerstin Junker, Homburg (DE) Radiation oncologist - Piet Ost, Ghent (BE) Coffee break and poster viewing Oral presentations of the 6 best abstracts Chairs: Medical oncologist - Susanne Osanto, Leiden (NL) Urologist - Hein Van Poppel, Leuven (BE) Radiation therapist - Barbara Jereczek-Fossa, Milan (IT) Highlights of Advanced Prostate Cancer Consensus Conference (APCCC2017) Medical oncologist - Silke Gillessen, St. Gallen (CH) Is there a shift for selection criteria and definition of reclassification for prostate cancer on active surveillance? Introduction: Pathologist - Rodolfo Montironi, Ancona (IT) Pathologist - Jonathan I. Epstein, Baltimore (US) Stand-alone session on recent updates/novelties Lunch break and poster viewing Industry session Management of loco/regional recurrences (prostate/penile cancer) Chairs: Medical oncologist - Silke Gillessen, St. Gallen (CH) Urologist - Georg Salomon, Hamburg (DE) Radiation therapist - Cesare Cozzarini, Milan (IT) MRI/whole body MRI

5 Radiologist - Frédéric Lecouvet, Brussels (BE) Use of PET/CT Nuclear medicine - Stefano Fanti, Bologna (IT) Salvage surgery after radiotherapy Urologist - Steven Joniau, Leuven (BE) Salvage treatment after radical prostatectomy Radiation oncologist - Alberto Bossi, Villejuif (FR) Management of local recurrences in penile cancer Urologist - Chris Protzel, Rostock (DE) Case discussion Case presenter: Urologist - Gianluca Giannarini, Udine (IT) Radiologist - Frédéric Lecouvet, Brussels (BE) Nuclear medicine - Stefano Fanti, Bologna (IT) Urologist - Steven Joniau, Leuven (BE) Radiation oncologist - Alberto Bossi, Villejuif (FR) Urologist - Chris Protzel, Rostock (DE) Coffee break and poster viewing Best of journals: Surgery Chairs: Urologist - Maurizio Brausi, Modena (IT) Urologist - Jochen Walz, Marseille (FR) Educational session: Challenging cases in the management of Upper urinary tract TCC Chairs : Urologist - Evanguelos Xylinas, Paris (FR) Urologist - Joan Palou, Barcelona (ES) Clinical case discussion (including peri-operative chemo, imaging, pathologist, biopsy) Case presenter: Urologist - Evanguelos Xylinas, Paris (FR) Clinical Oncologist - Ananya Choudhury, Machester (UK) Urologist - Morgan Roupret, Paris (FR) Radiologist - Raymond Oyen, Leuven (BE) Pathologist - Sara Falzarano, Cleveland (US) Industry session Sunday, 19 November Announcement 3 best unmoderated posters Chairs: Clinical oncologist - Jan Oldenburg, Oslo (NO) Urologist - Igle-Jan de Jong, Groningen (NL) Best of journals: Medical oncology

6 Chairs: Medical oncologist - Cora Sternberg, Rome (IT) Medical oncologist - Andrea Necchi, Milan (IT) Drug repurposing opportunities in uro-oncology Chairs: Medical oncologist - Cora Sternberg, Rome (IT) Urologist - Hein van Poppel, Leuven (BE) Dr. Director Anticancer fund - Gauthier Bouche, Strombeek-Bever (BE) Evolving concepts in metastatic prostate cancer Chairs: Medical oncologist - Cora Sternberg, Rome (IT) Urologist - Jeffrey Karnes, New York (US) Radiation therapist - David Dearnaley, Sutton (GB) How should we treat our metastatic castrate sensitive patients? Radiation oncologist - Nicholas James, Birmingham (GB) Monitoring patients with metastatic disease Radiologist - Anwar Padhani, Northwood (GB) Treatment of the primary in metastatic patients Urologist - Markus Graefen, Hamburg (DE) Molecular radiotherapy Radiologist - Uwe Haberkorn, Heidelberg (DE) Case discussion Urologist - Simon Brewster, Oxford (GB) European Commission lecture Director General for Health and Food Safety - Xavier Prats Monné, Barcelona (ES) Take home messages Radiologist - Raymond Oyen, Leuven (BE) Urologist - Igle-Jan de Jong, Groningen (NL) Clinical oncologist - Jan Oldenburg, Oslo (NO) Radiation oncologist - Bradley Pieters, Amsterdam (NL) Pathologist - Rodolfo Montironi, Ancona (IT) Closing remarks Clinical oncologist Radiation oncologist Urologist Jan Oldenburg, Oslo (NO) - ESMO Peter Hoskin, Northwood (GB) - ESTRO Hein van Poppel, Leuven (BE) - EAU